Literature DB >> 1710539

Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an Intergroup Rhabdomyosarcoma study project.

D M Parham1, B Webber, H Holt, W K Williams, H Maurer.   

Abstract

The authors assessed a panel of immunohistochemical stains against 109 pediatric solid tumors, primarily rhabdomyosarcomas, under the auspices of the Intergroup Rhabdomyosarcoma Study. Fresh tumor tissue received from participating organizations was divided into portions that were either frozen or fixed in formalin, alcohol, or B5. Immunostaining was performed by the avidin-biotin complex method using monoclonal antibodies to desmin, neurofilaments, vimentin, cytokeratin, and leukocyte common antigen on cryostat sections. Tissue was also embedded in paraffin and stained with antimuscle-specific actin (MSA) and polyclonal antibodies to desmin, creatine kinase M subunit (CKM), myoglobin, and neuron-specific enolase (NSE). Antidesmin staining of cryostat sections was the most sensitive indicator of rhabdomyosarcoma (58 of 62 specimens positive). Results with this reagent in alcohol-fixed and formalin-fixed tissue were similar (46 of 56 positive versus 43 of 56 positive, respectively) and comparable with results with anti-MSA in formalin-fixed tissue (43 of 55 positive). However, the proportion of cells stained by antidesmin was higher in alcohol-fixed tissue than in formalin-fixed tissue. Staining with antimyoglobin and anti-CKM was much less satisfactory, with positivity rates of 17 of 37 and 11 of 57, respectively, in formalin-fixed rhabdomyosarcomas. Immunostaining of muscle markers revealed evidence of myogenesis in six undifferentiated sarcomas and in two sarcomas with inadequate histologic study on hematoxylin-eosin-stained sections. However, positivity was also noticed in samples of fibromatosis, Wilms' tumor, ectomesenchyoma, peripheral primitive neuroectodermal tumor, renal rhabdoid tumor, myositis ossificans, malignant fibrous histiocytoma, and embryonal sarcoma of the liver. The authors conclude that combined use of antidesmin and anti-MSA enhances the diagnosis of childhood sarcomas, especially when employed with other techniques such as electron microscopic study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710539     DOI: 10.1002/1097-0142(19910615)67:12<3072::aid-cncr2820671223>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

Authors:  A Pandita; M Zielenska; P Thorner; J Bayani; R Godbout; M Greenberg; J A Squire
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement.

Authors:  L Krsková; M Mrhalová; D Sumerauer; R Kodet
Journal:  Virchows Arch       Date:  2005-12-20       Impact factor: 4.064

3.  The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.

Authors:  S Gattenloehner; A Vincent; I Leuschner; S Tzartos; H K Müller-Hermelink; T Kirchner; A Marx
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Orthopaedic case of the month: A 14-year-old boy with a medial thigh soft tissue mass.

Authors:  David A Ibrahim; Leo Mascarenhas; Jason P Tovar; Alexandre Arkader
Journal:  Clin Orthop Relat Res       Date:  2013-05       Impact factor: 4.176

5.  Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.

Authors:  P Dias; B Chen; B Dilday; H Palmer; H Hosoi; S Singh; C Wu; X Li; J Thompson; D Parham; S Qualman; P Houghton
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.

Authors:  B Chen; P Dias; J J Jenkins; V H Savell; D M Parham
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.

Authors:  G Tallini; D M Parham; P Dias; C Cordon-Cardo; P J Houghton; J Rosai
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma.

Authors:  J R Downing; A Khandekar; S A Shurtleff; D R Head; D M Parham; B L Webber; A S Pappo; M G Hulshof; W P Conn; D N Shapiro
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

9.  Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.

Authors:  N P Wang; J Marx; M A McNutt; J C Rutledge; A M Gown
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

10.  Immunocytochemistry: It's role in diagnosis of undifferentiated neoplasms by fine needle aspiration cytology.

Authors:  Palash Kumar Mandal; Santosh Kumar Mondal; Shravasti Roy; Anindya Adhikari; Nandita Basu; Swapan Kumar Sinha
Journal:  J Cytol       Date:  2013-04       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.